BIOSANTE Trademark

Trademark Overview

On Thursday, September 18, 2003, a trademark application was filed for BIOSANTE with the United States Patent and Trademark Office. The USPTO has given the BIOSANTE trademark a serial number of 78302295. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 12, 2014. This trademark is owned by BIOSANTE PHARMACEUTICALS, INC.. The BIOSANTE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, vaccines and vaccine adjuvants, nanoparticle vaccine adjuvants and drug delivery platforms, preparations for the administration of hormones, and pharmaceutically active compositions for the administration of drugs to the lungs, namely, suspensions, liquids or dry powders used as a drug delivery platform

General Information

Serial Number78302295
Word MarkBIOSANTE
Filing DateThursday, September 18, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 12, 2014
Registration Number3424013
Registration DateTuesday, May 6, 2008
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 22, 2004

Trademark Statements

Goods and ServicesPharmaceutical products, namely, vaccines and vaccine adjuvants, nanoparticle vaccine adjuvants and drug delivery platforms, preparations for the administration of hormones, and pharmaceutically active compositions for the administration of drugs to the lungs, namely, suspensions, liquids or dry powders used as a drug delivery platform

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 12, 2014
Primary Code005
First Use Anywhere DateTuesday, September 9, 2003
First Use In Commerce DateTuesday, September 9, 2003

Trademark Owner History

Party NameANI PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBAUDETTE, MN 56623
Party NameBIOSANTE PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069
Party NameBIOSANTE PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069
Party NameBIOSANTE PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069

Trademark Events

Event DateEvent Description
Friday, December 12, 2014CANCELLED SEC. 8 (6-YR)
Wednesday, January 1, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 23, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 23, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 6, 2008REGISTERED-PRINCIPAL REGISTER
Monday, March 31, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, March 31, 2008ASSIGNED TO LIE
Thursday, March 20, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 19, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 19, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 19, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 3, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 3, 2007NON-FINAL ACTION E-MAILED
Wednesday, October 3, 2007SU - NON-FINAL ACTION - WRITTEN
Friday, September 28, 2007STATEMENT OF USE PROCESSING COMPLETE
Friday, September 14, 2007USE AMENDMENT FILED
Friday, September 14, 2007TEAS STATEMENT OF USE RECEIVED
Thursday, February 22, 2007EXTENSION 5 GRANTED
Thursday, February 22, 2007EXTENSION 5 FILED
Thursday, February 22, 2007TEAS EXTENSION RECEIVED
Thursday, February 22, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 28, 2006EXTENSION 4 GRANTED
Thursday, September 14, 2006EXTENSION 4 FILED
Monday, September 18, 2006EXTENSION RECEIVED WITH TEAS PETITION
Monday, September 18, 2006PETITION TO REVIVE-GRANTED
Monday, September 18, 2006TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 14, 2006EXTENSION 3 GRANTED
Tuesday, February 14, 2006EXTENSION 3 FILED
Tuesday, February 14, 2006TEAS EXTENSION RECEIVED
Wednesday, September 7, 2005EXTENSION 2 GRANTED
Wednesday, September 7, 2005EXTENSION 2 FILED
Wednesday, September 7, 2005TEAS EXTENSION RECEIVED
Friday, April 1, 2005EXTENSION 1 GRANTED
Wednesday, March 9, 2005EXTENSION 1 FILED
Wednesday, March 9, 2005TEAS EXTENSION RECEIVED
Tuesday, September 14, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 22, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 2, 2004NOTICE OF PUBLICATION
Monday, April 19, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 19, 2004EXAMINERS AMENDMENT E-MAILED
Saturday, April 3, 2004ASSIGNED TO EXAMINER

Related Keywords

biosante adjuvants drug delivery vaccine administration namely suspensions lungs liquids drugs